Global Hepatitis A Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Description

Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.  Two types of HAV vaccines are currently available internationally:  1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).  2. Live attenuated vaccines (based on H2 or LA-1 HAV strains): These vaccines are manufactured and used mainly in China and sporadically in the private sector in India.

According to our (Global Info Research) latest study, the global Hepatitis A Vaccine market size was valued at US$ 757 million in 2023 and is forecast to a readjusted size of USD 880 million by 2030 with a CAGR of 2.2% during review period.

The Hepatitis A vaccine market is primarily driven by the increasing awareness of hepatitis prevention, coupled with growing vaccination programs initiated by governments and health organizations globally. As hepatitis A is a highly contagious liver infection, the rising incidence of outbreaks, especially in developing regions, is pushing demand for vaccines. Moreover, the expanding travel industry, where travelers are required to be vaccinated for hepatitis A when visiting certain high-risk regions, is further bolstering market growth. In addition, advancements in vaccine technology and the increasing availability of combination vaccines are also contributing factors. However, the market faces several challenges. One of the primary challenges is the high cost of vaccines, especially in low-income regions, limiting access for vulnerable populations. Additionally, the lack of infrastructure and healthcare facilities in remote areas poses a significant barrier to widespread vaccine distribution. In certain regions, vaccine hesitancy due to misinformation and fear of side effects also hampers market growth, making public health education and outreach essential to overcoming these obstacles.

Global hepatitis a vaccine key players include GSK, Merck, Sanofi, etc. Global top 5 manufacturers hold a share over 80%. Asia-Pacific  is the largest market, with a share over 38%, followed by North America and Europe , both have a share over 54%.  In terms of product, inactivated vaccine is the largest segment, with a share about 85%. And in terms of application, the largest application is government institution, followed by private sector, etc.

This report is a detailed and comprehensive analysis for global Hepatitis A Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:
Global Hepatitis A Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Unit), and average selling prices (USD/Unit), 2019-2030
Global Hepatitis A Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Unit), and average selling prices (USD/Unit), 2019-2030
Global Hepatitis A Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Unit), and average selling prices (USD/Unit), 2019-2030
Global Hepatitis A Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Unit), and ASP (USD/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Hepatitis A Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Hepatitis A Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, Merck, Sanofi, Sinovac, Zhejiang Pukang, Changchun Institute of Biological, KM Biologics, IMBCAMS, Convac, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation
Hepatitis A Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Inactivated Vaccine
    Live Attenuated Vaccine

Market segment by Application
    Government Institution
    Private Sector
    Other

Major players covered
    GSK
    Merck
    Sanofi
    Sinovac
    Zhejiang Pukang
    Changchun Institute of Biological
    KM Biologics
    IMBCAMS
    Convac

Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Hepatitis A Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Hepatitis A Vaccine, with price, sales quantity, revenue, and global market share of Hepatitis A Vaccine from 2019 to 2024.
Chapter 3, the Hepatitis A Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hepatitis A Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Hepatitis A Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Hepatitis A Vaccine.
Chapter 14 and 15, to describe Hepatitis A Vaccine sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Hepatitis A Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Inactivated Vaccine
        1.3.3 Live Attenuated Vaccine
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Hepatitis A Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Government Institution
        1.4.3 Private Sector
        1.4.4 Other
    1.5 Global Hepatitis A Vaccine Market Size & Forecast
        1.5.1 Global Hepatitis A Vaccine Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Hepatitis A Vaccine Sales Quantity (2019-2030)
        1.5.3 Global Hepatitis A Vaccine Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 GSK
        2.1.1 GSK Details
        2.1.2 GSK Major Business
        2.1.3 GSK Hepatitis A Vaccine Product and Services
        2.1.4 GSK Hepatitis A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 GSK Recent Developments/Updates
    2.2 Merck
        2.2.1 Merck Details
        2.2.2 Merck Major Business
        2.2.3 Merck Hepatitis A Vaccine Product and Services
        2.2.4 Merck Hepatitis A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Merck Recent Developments/Updates
    2.3 Sanofi
        2.3.1 Sanofi Details
        2.3.2 Sanofi Major Business
        2.3.3 Sanofi Hepatitis A Vaccine Product and Services
        2.3.4 Sanofi Hepatitis A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Sanofi Recent Developments/Updates
    2.4 Sinovac
        2.4.1 Sinovac Details
        2.4.2 Sinovac Major Business
        2.4.3 Sinovac Hepatitis A Vaccine Product and Services
        2.4.4 Sinovac Hepatitis A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Sinovac Recent Developments/Updates
    2.5 Zhejiang Pukang
        2.5.1 Zhejiang Pukang Details
        2.5.2 Zhejiang Pukang Major Business
        2.5.3 Zhejiang Pukang Hepatitis A Vaccine Product and Services
        2.5.4 Zhejiang Pukang Hepatitis A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Zhejiang Pukang Recent Developments/Updates
    2.6 Changchun Institute of Biological
        2.6.1 Changchun Institute of Biological Details
        2.6.2 Changchun Institute of Biological Major Business
        2.6.3 Changchun Institute of Biological Hepatitis A Vaccine Product and Services
        2.6.4 Changchun Institute of Biological Hepatitis A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Changchun Institute of Biological Recent Developments/Updates
    2.7 KM Biologics
        2.7.1 KM Biologics Details
        2.7.2 KM Biologics Major Business
        2.7.3 KM Biologics Hepatitis A Vaccine Product and Services
        2.7.4 KM Biologics Hepatitis A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 KM Biologics Recent Developments/Updates
    2.8 IMBCAMS
        2.8.1 IMBCAMS Details
        2.8.2 IMBCAMS Major Business
        2.8.3 IMBCAMS Hepatitis A Vaccine Product and Services
        2.8.4 IMBCAMS Hepatitis A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 IMBCAMS Recent Developments/Updates
    2.9 Convac
        2.9.1 Convac Details
        2.9.2 Convac Major Business
        2.9.3 Convac Hepatitis A Vaccine Product and Services
        2.9.4 Convac Hepatitis A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Convac Recent Developments/Updates

3 Competitive Environment: Hepatitis A Vaccine by Manufacturer
    3.1 Global Hepatitis A Vaccine Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Hepatitis A Vaccine Revenue by Manufacturer (2019-2024)
    3.3 Global Hepatitis A Vaccine Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Hepatitis A Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Hepatitis A Vaccine Manufacturer Market Share in 2023
        3.4.3 Top 6 Hepatitis A Vaccine Manufacturer Market Share in 2023
    3.5 Hepatitis A Vaccine Market: Overall Company Footprint Analysis
        3.5.1 Hepatitis A Vaccine Market: Region Footprint
        3.5.2 Hepatitis A Vaccine Market: Company Product Type Footprint
        3.5.3 Hepatitis A Vaccine Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Hepatitis A Vaccine Market Size by Region
        4.1.1 Global Hepatitis A Vaccine Sales Quantity by Region (2019-2030)
        4.1.2 Global Hepatitis A Vaccine Consumption Value by Region (2019-2030)
        4.1.3 Global Hepatitis A Vaccine Average Price by Region (2019-2030)
    4.2 North America Hepatitis A Vaccine Consumption Value (2019-2030)
    4.3 Europe Hepatitis A Vaccine Consumption Value (2019-2030)
    4.4 Asia-Pacific Hepatitis A Vaccine Consumption Value (2019-2030)
    4.5 South America Hepatitis A Vaccine Consumption Value (2019-2030)
    4.6 Middle East & Africa Hepatitis A Vaccine Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Hepatitis A Vaccine Sales Quantity by Type (2019-2030)
    5.2 Global Hepatitis A Vaccine Consumption Value by Type (2019-2030)
    5.3 Global Hepatitis A Vaccine Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Hepatitis A Vaccine Sales Quantity by Application (2019-2030)
    6.2 Global Hepatitis A Vaccine Consumption Value by Application (2019-2030)
    6.3 Global Hepatitis A Vaccine Average Price by Application (2019-2030)

7 North America
    7.1 North America Hepatitis A Vaccine Sales Quantity by Type (2019-2030)
    7.2 North America Hepatitis A Vaccine Sales Quantity by Application (2019-2030)
    7.3 North America Hepatitis A Vaccine Market Size by Country
        7.3.1 North America Hepatitis A Vaccine Sales Quantity by Country (2019-2030)
        7.3.2 North America Hepatitis A Vaccine Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Hepatitis A Vaccine Sales Quantity by Type (2019-2030)
    8.2 Europe Hepatitis A Vaccine Sales Quantity by Application (2019-2030)
    8.3 Europe Hepatitis A Vaccine Market Size by Country
        8.3.1 Europe Hepatitis A Vaccine Sales Quantity by Country (2019-2030)
        8.3.2 Europe Hepatitis A Vaccine Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Hepatitis A Vaccine Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Hepatitis A Vaccine Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Hepatitis A Vaccine Market Size by Region
        9.3.1 Asia-Pacific Hepatitis A Vaccine Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Hepatitis A Vaccine Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 South Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Hepatitis A Vaccine Sales Quantity by Type (2019-2030)
    10.2 South America Hepatitis A Vaccine Sales Quantity by Application (2019-2030)
    10.3 South America Hepatitis A Vaccine Market Size by Country
        10.3.1 South America Hepatitis A Vaccine Sales Quantity by Country (2019-2030)
        10.3.2 South America Hepatitis A Vaccine Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Hepatitis A Vaccine Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Hepatitis A Vaccine Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Hepatitis A Vaccine Market Size by Country
        11.3.1 Middle East & Africa Hepatitis A Vaccine Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Hepatitis A Vaccine Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Hepatitis A Vaccine Market Drivers
    12.2 Hepatitis A Vaccine Market Restraints
    12.3 Hepatitis A Vaccine Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Hepatitis A Vaccine and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Hepatitis A Vaccine
    13.3 Hepatitis A Vaccine Production Process
    13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Hepatitis A Vaccine Typical Distributors
    14.3 Hepatitis A Vaccine Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Hepatitis A Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 2. Global Hepatitis A Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 3. GSK Basic Information, Manufacturing Base and Competitors
 Table 4. GSK Major Business
 Table 5. GSK Hepatitis A Vaccine Product and Services
 Table 6. GSK Hepatitis A Vaccine Sales Quantity (K Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 7. GSK Recent Developments/Updates
 Table 8. Merck Basic Information, Manufacturing Base and Competitors
 Table 9. Merck Major Business
 Table 10. Merck Hepatitis A Vaccine Product and Services
 Table 11. Merck Hepatitis A Vaccine Sales Quantity (K Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 12. Merck Recent Developments/Updates
 Table 13. Sanofi Basic Information, Manufacturing Base and Competitors
 Table 14. Sanofi Major Business
 Table 15. Sanofi Hepatitis A Vaccine Product and Services
 Table 16. Sanofi Hepatitis A Vaccine Sales Quantity (K Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 17. Sanofi Recent Developments/Updates
 Table 18. Sinovac Basic Information, Manufacturing Base and Competitors
 Table 19. Sinovac Major Business
 Table 20. Sinovac Hepatitis A Vaccine Product and Services
 Table 21. Sinovac Hepatitis A Vaccine Sales Quantity (K Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 22. Sinovac Recent Developments/Updates
 Table 23. Zhejiang Pukang Basic Information, Manufacturing Base and Competitors
 Table 24. Zhejiang Pukang Major Business
 Table 25. Zhejiang Pukang Hepatitis A Vaccine Product and Services
 Table 26. Zhejiang Pukang Hepatitis A Vaccine Sales Quantity (K Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 27. Zhejiang Pukang Recent Developments/Updates
 Table 28. Changchun Institute of Biological Basic Information, Manufacturing Base and Competitors
 Table 29. Changchun Institute of Biological Major Business
 Table 30. Changchun Institute of Biological Hepatitis A Vaccine Product and Services
 Table 31. Changchun Institute of Biological Hepatitis A Vaccine Sales Quantity (K Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 32. Changchun Institute of Biological Recent Developments/Updates
 Table 33. KM Biologics Basic Information, Manufacturing Base and Competitors
 Table 34. KM Biologics Major Business
 Table 35. KM Biologics Hepatitis A Vaccine Product and Services
 Table 36. KM Biologics Hepatitis A Vaccine Sales Quantity (K Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 37. KM Biologics Recent Developments/Updates
 Table 38. IMBCAMS Basic Information, Manufacturing Base and Competitors
 Table 39. IMBCAMS Major Business
 Table 40. IMBCAMS Hepatitis A Vaccine Product and Services
 Table 41. IMBCAMS Hepatitis A Vaccine Sales Quantity (K Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 42. IMBCAMS Recent Developments/Updates
 Table 43. Convac Basic Information, Manufacturing Base and Competitors
 Table 44. Convac Major Business
 Table 45. Convac Hepatitis A Vaccine Product and Services
 Table 46. Convac Hepatitis A Vaccine Sales Quantity (K Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 47. Convac Recent Developments/Updates
 Table 48. Global Hepatitis A Vaccine Sales Quantity by Manufacturer (2019-2024) & (K Unit)
 Table 49. Global Hepatitis A Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
 Table 50. Global Hepatitis A Vaccine Average Price by Manufacturer (2019-2024) & (USD/Unit)
 Table 51. Market Position of Manufacturers in Hepatitis A Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
 Table 52. Head Office and Hepatitis A Vaccine Production Site of Key Manufacturer
 Table 53. Hepatitis A Vaccine Market: Company Product Type Footprint
 Table 54. Hepatitis A Vaccine Market: Company Product Application Footprint
 Table 55. Hepatitis A Vaccine New Market Entrants and Barriers to Market Entry
 Table 56. Hepatitis A Vaccine Mergers, Acquisition, Agreements, and Collaborations
 Table 57. Global Hepatitis A Vaccine Consumption Value by Region (2019-2023-2030) & (USD Million) & CAGR
 Table 58. Global Hepatitis A Vaccine Sales Quantity by Region (2019-2024) & (K Unit)
 Table 59. Global Hepatitis A Vaccine Sales Quantity by Region (2025-2030) & (K Unit)
 Table 60. Global Hepatitis A Vaccine Consumption Value by Region (2019-2024) & (USD Million)
 Table 61. Global Hepatitis A Vaccine Consumption Value by Region (2025-2030) & (USD Million)
 Table 62. Global Hepatitis A Vaccine Average Price by Region (2019-2024) & (USD/Unit)
 Table 63. Global Hepatitis A Vaccine Average Price by Region (2025-2030) & (USD/Unit)
 Table 64. Global Hepatitis A Vaccine Sales Quantity by Type (2019-2024) & (K Unit)
 Table 65. Global Hepatitis A Vaccine Sales Quantity by Type (2025-2030) & (K Unit)
 Table 66. Global Hepatitis A Vaccine Consumption Value by Type (2019-2024) & (USD Million)
 Table 67. Global Hepatitis A Vaccine Consumption Value by Type (2025-2030) & (USD Million)
 Table 68. Global Hepatitis A Vaccine Average Price by Type (2019-2024) & (USD/Unit)
 Table 69. Global Hepatitis A Vaccine Average Price by Type (2025-2030) & (USD/Unit)
 Table 70. Global Hepatitis A Vaccine Sales Quantity by Application (2019-2024) & (K Unit)
 Table 71. Global Hepatitis A Vaccine Sales Quantity by Application (2025-2030) & (K Unit)
 Table 72. Global Hepatitis A Vaccine Consumption Value by Application (2019-2024) & (USD Million)
 Table 73. Global Hepatitis A Vaccine Consumption Value by Application (2025-2030) & (USD Million)
 Table 74. Global Hepatitis A Vaccine Average Price by Application (2019-2024) & (USD/Unit)
 Table 75. Global Hepatitis A Vaccine Average Price by Application (2025-2030) & (USD/Unit)
 Table 76. North America Hepatitis A Vaccine Sales Quantity by Type (2019-2024) & (K Unit)
 Table 77. North America Hepatitis A Vaccine Sales Quantity by Type (2025-2030) & (K Unit)
 Table 78. North America Hepatitis A Vaccine Sales Quantity by Application (2019-2024) & (K Unit)
 Table 79. North America Hepatitis A Vaccine Sales Quantity by Application (2025-2030) & (K Unit)
 Table 80. North America Hepatitis A Vaccine Sales Quantity by Country (2019-2024) & (K Unit)
 Table 81. North America Hepatitis A Vaccine Sales Quantity by Country (2025-2030) & (K Unit)
 Table 82. North America Hepatitis A Vaccine Consumption Value by Country (2019-2024) & (USD Million)
 Table 83. North America Hepatitis A Vaccine Consumption Value by Country (2025-2030) & (USD Million)
 Table 84. Europe Hepatitis A Vaccine Sales Quantity by Type (2019-2024) & (K Unit)
 Table 85. Europe Hepatitis A Vaccine Sales Quantity by Type (2025-2030) & (K Unit)
 Table 86. Europe Hepatitis A Vaccine Sales Quantity by Application (2019-2024) & (K Unit)
 Table 87. Europe Hepatitis A Vaccine Sales Quantity by Application (2025-2030) & (K Unit)
 Table 88. Europe Hepatitis A Vaccine Sales Quantity by Country (2019-2024) & (K Unit)
 Table 89. Europe Hepatitis A Vaccine Sales Quantity by Country (2025-2030) & (K Unit)
 Table 90. Europe Hepatitis A Vaccine Consumption Value by Country (2019-2024) & (USD Million)
 Table 91. Europe Hepatitis A Vaccine Consumption Value by Country (2025-2030) & (USD Million)
 Table 92. Asia-Pacific Hepatitis A Vaccine Sales Quantity by Type (2019-2024) & (K Unit)
 Table 93. Asia-Pacific Hepatitis A Vaccine Sales Quantity by Type (2025-2030) & (K Unit)
 Table 94. Asia-Pacific Hepatitis A Vaccine Sales Quantity by Application (2019-2024) & (K Unit)
 Table 95. Asia-Pacific Hepatitis A Vaccine Sales Quantity by Application (2025-2030) & (K Unit)
 Table 96. Asia-Pacific Hepatitis A Vaccine Sales Quantity by Region (2019-2024) & (K Unit)
 Table 97. Asia-Pacific Hepatitis A Vaccine Sales Quantity by Region (2025-2030) & (K Unit)
 Table 98. Asia-Pacific Hepatitis A Vaccine Consumption Value by Region (2019-2024) & (USD Million)
 Table 99. Asia-Pacific Hepatitis A Vaccine Consumption Value by Region (2025-2030) & (USD Million)
 Table 100. South America Hepatitis A Vaccine Sales Quantity by Type (2019-2024) & (K Unit)
 Table 101. South America Hepatitis A Vaccine Sales Quantity by Type (2025-2030) & (K Unit)
 Table 102. South America Hepatitis A Vaccine Sales Quantity by Application (2019-2024) & (K Unit)
 Table 103. South America Hepatitis A Vaccine Sales Quantity by Application (2025-2030) & (K Unit)
 Table 104. South America Hepatitis A Vaccine Sales Quantity by Country (2019-2024) & (K Unit)
 Table 105. South America Hepatitis A Vaccine Sales Quantity by Country (2025-2030) & (K Unit)
 Table 106. South America Hepatitis A Vaccine Consumption Value by Country (2019-2024) & (USD Million)
 Table 107. South America Hepatitis A Vaccine Consumption Value by Country (2025-2030) & (USD Million)
 Table 108. Middle East & Africa Hepatitis A Vaccine Sales Quantity by Type (2019-2024) & (K Unit)
 Table 109. Middle East & Africa Hepatitis A Vaccine Sales Quantity by Type (2025-2030) & (K Unit)
 Table 110. Middle East & Africa Hepatitis A Vaccine Sales Quantity by Application (2019-2024) & (K Unit)
 Table 111. Middle East & Africa Hepatitis A Vaccine Sales Quantity by Application (2025-2030) & (K Unit)
 Table 112. Middle East & Africa Hepatitis A Vaccine Sales Quantity by Country (2019-2024) & (K Unit)
 Table 113. Middle East & Africa Hepatitis A Vaccine Sales Quantity by Country (2025-2030) & (K Unit)
 Table 114. Middle East & Africa Hepatitis A Vaccine Consumption Value by Country (2019-2024) & (USD Million)
 Table 115. Middle East & Africa Hepatitis A Vaccine Consumption Value by Country (2025-2030) & (USD Million)
 Table 116. Hepatitis A Vaccine Raw Material
 Table 117. Key Manufacturers of Hepatitis A Vaccine Raw Materials
 Table 118. Hepatitis A Vaccine Typical Distributors
 Table 119. Hepatitis A Vaccine Typical Customers


List of Figures
 Figure 1. Hepatitis A Vaccine Picture
 Figure 2. Global Hepatitis A Vaccine Revenue by Type, (USD Million), 2019 & 2023 & 2030
 Figure 3. Global Hepatitis A Vaccine Revenue Market Share by Type in 2023
 Figure 4. Inactivated Vaccine Examples
 Figure 5. Live Attenuated Vaccine Examples
 Figure 6. Global Hepatitis A Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 7. Global Hepatitis A Vaccine Revenue Market Share by Application in 2023
 Figure 8. Government Institution Examples
 Figure 9. Private Sector Examples
 Figure 10. Other Examples
 Figure 11. Global Hepatitis A Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
 Figure 12. Global Hepatitis A Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
 Figure 13. Global Hepatitis A Vaccine Sales Quantity (2019-2030) & (K Unit)
 Figure 14. Global Hepatitis A Vaccine Price (2019-2030) & (USD/Unit)
 Figure 15. Global Hepatitis A Vaccine Sales Quantity Market Share by Manufacturer in 2023
 Figure 16. Global Hepatitis A Vaccine Revenue Market Share by Manufacturer in 2023
 Figure 17. Producer Shipments of Hepatitis A Vaccine by Manufacturer Sales ($MM) and Market Share (%): 2023
 Figure 18. Top 3 Hepatitis A Vaccine Manufacturer (Revenue) Market Share in 2023
 Figure 19. Top 6 Hepatitis A Vaccine Manufacturer (Revenue) Market Share in 2023
 Figure 20. Global Hepatitis A Vaccine Sales Quantity Market Share by Region (2019-2030)
 Figure 21. Global Hepatitis A Vaccine Consumption Value Market Share by Region (2019-2030)
 Figure 22. North America Hepatitis A Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 23. Europe Hepatitis A Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 24. Asia-Pacific Hepatitis A Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 25. South America Hepatitis A Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 26. Middle East & Africa Hepatitis A Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 27. Global Hepatitis A Vaccine Sales Quantity Market Share by Type (2019-2030)
 Figure 28. Global Hepatitis A Vaccine Consumption Value Market Share by Type (2019-2030)
 Figure 29. Global Hepatitis A Vaccine Average Price by Type (2019-2030) & (USD/Unit)
 Figure 30. Global Hepatitis A Vaccine Sales Quantity Market Share by Application (2019-2030)
 Figure 31. Global Hepatitis A Vaccine Revenue Market Share by Application (2019-2030)
 Figure 32. Global Hepatitis A Vaccine Average Price by Application (2019-2030) & (USD/Unit)
 Figure 33. North America Hepatitis A Vaccine Sales Quantity Market Share by Type (2019-2030)
 Figure 34. North America Hepatitis A Vaccine Sales Quantity Market Share by Application (2019-2030)
 Figure 35. North America Hepatitis A Vaccine Sales Quantity Market Share by Country (2019-2030)
 Figure 36. North America Hepatitis A Vaccine Consumption Value Market Share by Country (2019-2030)
 Figure 37. United States Hepatitis A Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 38. Canada Hepatitis A Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 39. Mexico Hepatitis A Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 40. Europe Hepatitis A Vaccine Sales Quantity Market Share by Type (2019-2030)
 Figure 41. Europe Hepatitis A Vaccine Sales Quantity Market Share by Application (2019-2030)
 Figure 42. Europe Hepatitis A Vaccine Sales Quantity Market Share by Country (2019-2030)
 Figure 43. Europe Hepatitis A Vaccine Consumption Value Market Share by Country (2019-2030)
 Figure 44. Germany Hepatitis A Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 45. France Hepatitis A Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 46. United Kingdom Hepatitis A Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 47. Russia Hepatitis A Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 48. Italy Hepatitis A Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 49. Asia-Pacific Hepatitis A Vaccine Sales Quantity Market Share by Type (2019-2030)
 Figure 50. Asia-Pacific Hepatitis A Vaccine Sales Quantity Market Share by Application (2019-2030)
 Figure 51. Asia-Pacific Hepatitis A Vaccine Sales Quantity Market Share by Region (2019-2030)
 Figure 52. Asia-Pacific Hepatitis A Vaccine Consumption Value Market Share by Region (2019-2030)
 Figure 53. China Hepatitis A Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 54. Japan Hepatitis A Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 55. South Korea Hepatitis A Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 56. India Hepatitis A Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 57. Southeast Asia Hepatitis A Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 58. Australia Hepatitis A Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 59. South America Hepatitis A Vaccine Sales Quantity Market Share by Type (2019-2030)
 Figure 60. South America Hepatitis A Vaccine Sales Quantity Market Share by Application (2019-2030)
 Figure 61. South America Hepatitis A Vaccine Sales Quantity Market Share by Country (2019-2030)
 Figure 62. South America Hepatitis A Vaccine Consumption Value Market Share by Country (2019-2030)
 Figure 63. Brazil Hepatitis A Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 64. Argentina Hepatitis A Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 65. Middle East & Africa Hepatitis A Vaccine Sales Quantity Market Share by Type (2019-2030)
 Figure 66. Middle East & Africa Hepatitis A Vaccine Sales Quantity Market Share by Application (2019-2030)
 Figure 67. Middle East & Africa Hepatitis A Vaccine Sales Quantity Market Share by Country (2019-2030)
 Figure 68. Middle East & Africa Hepatitis A Vaccine Consumption Value Market Share by Country (2019-2030)
 Figure 69. Turkey Hepatitis A Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 70. Egypt Hepatitis A Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 71. Saudi Arabia Hepatitis A Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 72. South Africa Hepatitis A Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 73. Hepatitis A Vaccine Market Drivers
 Figure 74. Hepatitis A Vaccine Market Restraints
 Figure 75. Hepatitis A Vaccine Market Trends
 Figure 76. Porters Five Forces Analysis
 Figure 77. Manufacturing Cost Structure Analysis of Hepatitis A Vaccine in 2023
 Figure 78. Manufacturing Process Analysis of Hepatitis A Vaccine
 Figure 79. Hepatitis A Vaccine Industrial Chain
 Figure 80. Sales Channel: Direct to End-User vs Distributors
 Figure 81. Direct Channel Pros & Cons
 Figure 82. Indirect Channel Pros & Cons
 Figure 83. Methodology
 Figure 84. Research Process and Data Source

Companies Mentioned

GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
KM Biologics
IMBCAMS
Convac